SU425630A1 - PREPARATION FOR THE TREATMENT OF MASTITIES OF AGRICULTURAL ANIMALS - Google Patents
PREPARATION FOR THE TREATMENT OF MASTITIES OF AGRICULTURAL ANIMALSInfo
- Publication number
- SU425630A1 SU425630A1 SU1730095A SU1730095A SU425630A1 SU 425630 A1 SU425630 A1 SU 425630A1 SU 1730095 A SU1730095 A SU 1730095A SU 1730095 A SU1730095 A SU 1730095A SU 425630 A1 SU425630 A1 SU 425630A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- treatment
- preparation
- mastities
- agricultural animals
- drug
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
1one
Изобретение касаетс лекарственных средств дл лечени воспалений молочной железы сельскохоз йственных животных.The invention relates to medicaments for treating inflammations of the mammary gland of agricultural animals.
Известные препараты дл лечени маститов , например «Мастисан-А или тетрациклипова мазь, имеют в своем составе повышенную концентрацию антибиотиков, что может вызвать раздражение молочной железы и делает непригодным к употреблению в пищу молоко, получаемое от животного в период лечени .Known drugs for the treatment of mastitis, for example, Mastisan-A or tetracycline ointment, contain an increased concentration of antibiotics, which can cause irritation of the mammary gland and renders the milk received from an animal during the treatment period unsuitable for human consumption.
С целью уменьшени концентрации активных веществ без снижени лечебного эффекта в предложенный препарат в качестве эмульгатора введен дистеарат полиглицерина, а в качестве пролонгатора - метилурацил.In order to reduce the concentration of active substances without reducing the therapeutic effect, polyglycerol distearate was introduced into the proposed drug as an emulsifier, and methyluracil as a prolongator.
Препарат может иметь следующее соотношение компонентов, вес. %:The drug may have the following ratio of components, weight. %:
Иеомицин сульфат0,8-1,0Jeomycin Sulfate 0.8-1.0
Сульфадимезин4,0-6,0Sulfadimezin4,0-6,0
Метилурацил5,0-7,0Methyluracil5.0-7.0
Дистеарат полиглицерина3,5-4,0Polyglycerol distearate3,5-4,0
Вазелиновое масло86,5-81,5Vaseline oil86,5-81,5
Оптимальным соотношением вл етс следующее: неомицин сульфат 25000 М. Е., сульфадимезин 0,25 г, метилурацил 0,35 г, дистеарат полиглицерина 0,2 г, вазелиновое масло до 5 г.The optimal ratio is the following: neomycin sulfate 25000 M.U., sulfadimezin 0.25 g, methyluracil 0.35 g, polyglycerol distearate 0.2 g, liquid paraffin up to 5 g
Перед интрацистернальным введением препарата его рекомендуетс подогревать до 35-37°С. Введение может быть легко осуществлено с помощью эластичного катетера илиIt is recommended to warm it up to 35-37 ° C before intracisternal administration of the drug. The insertion can be easily accomplished with an elastic catheter or
шприц-тюбиков, в которых он выпускаетс под условным наименованием «Мастисан-Б. Препарат равномерно распредел етс в цистерне и молочных протоках вымени, хорошо всасываетс в ткани паренхимы, эффективно нодавл ет рост как грамотрицательпых, так и грамположительных бактерий, способствует регенерации тканей вымени и может найти широкое применение дл борьбы со скрытыми и клиническими формами маститов, аsyringe tubes in which it is manufactured under the code name Mastisan-B. The drug is evenly distributed in the cistern and the milk ducts of the udder, is well absorbed in the parenchyma tissue, effectively suppresses the growth of both gram-negative and gram-positive bacteria, promotes the regeneration of the udder tissues and can be widely used to combat the hidden and clinical forms of mastitis
также травматическими повреждени ми кожи вымени и сосков в комплексе с другими методами лечени .also traumatic injuries to the skin of the udder and nipples in combination with other methods of treatment.
Предмет изобретени Subject invention
Препарат дл лечени маститов сельскохоз йственных животных, состо щий из активных веществ, нанример антибиотиков: неомнцина и сульфадимезина, эмульгатора, пролонгатора и масл ной основы, о т л и ч а ю щ и йс тем, что, с целью уменьшени концентрации активных веществ без снижени лечебного эффекта препарата, в качестве эмульгатора в его состав введен дистеарат полиглицерипа, а в качестве пролонгатора - метил рацил.A preparation for the treatment of mastitis of agricultural animals, consisting of active substances, an example of antibiotics: neomncin and sulfadimezin, emulsifier, prolongator and oil base, in order to reduce the concentration of active substances without reducing the therapeutic effect of the drug; polyglyceride distearate was introduced into its composition, and methyl racil as a prolongator.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU1730095A SU425630A1 (en) | 1971-12-27 | 1971-12-27 | PREPARATION FOR THE TREATMENT OF MASTITIES OF AGRICULTURAL ANIMALS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU1730095A SU425630A1 (en) | 1971-12-27 | 1971-12-27 | PREPARATION FOR THE TREATMENT OF MASTITIES OF AGRICULTURAL ANIMALS |
Publications (1)
Publication Number | Publication Date |
---|---|
SU425630A1 true SU425630A1 (en) | 1974-04-30 |
Family
ID=20497741
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU1730095A SU425630A1 (en) | 1971-12-27 | 1971-12-27 | PREPARATION FOR THE TREATMENT OF MASTITIES OF AGRICULTURAL ANIMALS |
Country Status (1)
Country | Link |
---|---|
SU (1) | SU425630A1 (en) |
-
1971
- 1971-12-27 SU SU1730095A patent/SU425630A1/en active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1335262C (en) | Pharmaceutical composition for treatment of mastitis in amimals and humans | |
SU425630A1 (en) | PREPARATION FOR THE TREATMENT OF MASTITIES OF AGRICULTURAL ANIMALS | |
RU2598338C1 (en) | Method for the treatment of serous mastitis in cattle | |
RU2157696C2 (en) | Method for treating the cases of latent cow mastitis | |
RU2058782C1 (en) | Preparation for treatment and prophylaxis of mastitis in cattle at dry period | |
RU2030180C1 (en) | Method for treatment of endometritis at cow | |
RU2706124C1 (en) | Method of treating subclinical mastitis of cows | |
RU2320325C1 (en) | Method for treating inspecific mastitis in cows | |
RU2058781C1 (en) | Preparation for treatment and prophylaxis of mastitis in cattle at dry period | |
RU2745236C1 (en) | Method of treatment and prevention of subclinical mastitis of cows | |
RU2779877C1 (en) | Method for treatment of mastitis in cows during the dry period | |
RU2524623C1 (en) | Method of combination treatment of chronic endometritis in cows | |
RU2787754C1 (en) | Method for treatment of mastitis in cattle | |
RU2757329C1 (en) | Method for therapy of cow catarral mastitis with complex preparation containing silver nanoparticles argovit and dimexide | |
RU2228176C2 (en) | Method for treating mastitis in cows | |
RU2538051C2 (en) | Method of treating latent mastitis in cows | |
RU2227024C2 (en) | Emulsion "endometritsit" for prophylaxis and treatment of postpartum diseases in cows | |
RU2145499C1 (en) | Preparation gastropulmin for treatment and prophylaxis of gastro-enteric and respiratory sicknesses in newborn calves and lambs | |
RU2201756C2 (en) | Method for prophylaxis and treatment of mastitis in cows | |
RU2423990C1 (en) | Method of treating mastitis in cows | |
CN108420829B (en) | Detumescence granulation promoting paste for pets | |
RU2251267C1 (en) | Insecticidal composition for controlling gadffly's larvae | |
RU2180221C2 (en) | Method to treat subclinical mastitis in cows | |
RU2203650C2 (en) | Preparation for treating mastitis in cows | |
Knotek | Therapeutics and medication |